Xeljanz Blood Clots and Deaths: Black-Box Warning Issued
In July 2019, the U.S. Food and Drug Administration approved a black-box warning for the Xeljanz (tofacitinib) drug label due to a higher risk of blood clots and death. The changes followed a review [...]